Zobrazeno 1 - 7
of 7
pro vyhledávání: ''
Autor:
Antonia Strippoli, Alessandra Cocomazzi, Carmelo Pozzo, Maria Alessandra Calegari, Michele Basso, Riccardo Ricci, Carlo Barone, Mariantonietta Di Salvatore, I. Zurlo, Mattia Schino, Giampaolo Tortora, Maurizio Martini, Alessandra Cassano, Luigi Maria Larocca, Emilio Bria
Publikováno v:
Cancer Immunology, Immunotherapy
The combination of perioperative chemotherapy plus complete surgical resection is currently accounted as the first-choice strategy in patients with locally advanced Gastric Cancer (LAGC). Nevertheless, the partial response rate makes it necessary to
Autor:
Oliver Bähr, Katharina Filipski, Michael W. Ronellenfitsch, Iris Divé, Joachim P. Steinbach, Marie Therese Forster, Pia S. Zeiner, Patrick N. Harter, Emmanouil Fokas, Marlies Wagner, Eike Steidl
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Purpose Classification and treatment of WHO grade II/III gliomas have dramatically changed. Implementing molecular markers into the WHO classification raised discussions about the significance of grading and clinical trials showed overall survival (O
Autor:
Darshana Patil, Sewanti Limaye, Amit Bhatt, Prashant Kumar, Tim Crook, Sanket Patil, Raymond L. Page, Anantbhushan Ranade, Dadasaheb Akolkar, Andrew Gaya
Publikováno v:
Cancer Chemotherapy and Pharmacology
Purpose Selection of cytotoxic chemotherapy agents (CCA) based on pre-treatment evaluation of drug sensitivities is a desirable but unmet goal for personalized anticancer treatment strategies. Prior attempts to correlate in vitro Chemo-Response Profi
Autor:
Utz Settmacher, Herman Kissler, Annelore Altendorf-Hofmann, A. Bauschke, Michael Ardelt, Hans-Michael Tautenhahn
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Background It has been shown that local ablative procedures enable downsizing, reduce drop-out from the waiting list and improve prognosis after liver transplantation. It is still unclear whether a response to the local ablative therapy is due to a f
Autor:
Claire F. Verschraegen, Daniel Spakowicz, Mingjia Li, Kai He, Jarred Burkart, Kari Kendra, Erin M. Bertino, Gregory A. Otterson, Dwight H. Owen, Sandip H. Patel, Carolyn J Presley, Marium Husain, David P. Carbone, Peter G. Shields
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Background The neutrophil to lymphocyte ratio (NLR) is known to be prognostic for patients with advanced cancers treated with immune checkpoint inhibitors (ICI), but has generally been evaluated as a single threshold value at baseline. We evaluated N
Autor:
Josef Fritz, Andrea Brunner, Dietmar Fuchs, Andrea Rahm, Martin Thurnher, Georg Gruenbacher, Hubert Gander, Renate Pichler, Zoran Culig
Publikováno v:
Cancer Immunology, Immunotherapy
Th1-type immunity is considered to be required for efficient response to BCG in bladder cancer, although Th2 predisposition of BCG responders has recently been reported. The aim was to evaluate the relationship of Th1 and Th2 components in 23 patient
Autor:
Radoslav Chekerov, Desislava Dimitrova, Jalid Sehouli, Mustafa Zelal Muallem, Ingo B. Runnebaum, Michael P. Lux, Hans Werner Tessen, Oliver Tome, Oumar Camara, Beate Rautenberg, Tanja Trarbach, Gerald Gitsch
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Objective In recurrent ovarian cancer (ROC), there is a high demand on effective therapies with a mild toxicity profile. Treosulfan is an alkylating agent approved as oral (p.o.) and intravenous (i.v.) formulation for the treatment of recurrent ovari